| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 163.64 Million |
| Market Size (2030) | USD 294.21 Million |
| CAGR (2025 - 2030) | 12.45 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Smart Insulin Pens Market Analysis
The Smart Insulin Pens Market size is estimated at USD 163.64 million in 2025, and is expected to reach USD 294.21 million by 2030, at a CAGR of 12.45% during the forecast period (2025-2030).
Certain factors propelling the market growth include the rising prevalence of diabetes, the growing patient preference for smart insulin pens, and technological advancements. Additionally, the activities of prominent players such as acquisition and partnership are expected to be the significant factors for the studied market growth.
The rising prevalence of diabetes is driving the growth of the smart insulin pens market, as the increasing number of diagnoses fuels demand for advanced insulin delivery systems that offer enhanced convenience and improved glucose management. For instance, according to a report published by the Diabetics Journal in February 2024, the prevalence of diabetes in Germany is projected to increase significantly by 2040, with an estimated growth rate of 54-77%. This projection refers to the total population affected by diabetes, highlighting a rising healthcare burden and potential market opportunities in diabetes management and treatment solutions.
Moreover, as per the Indian Council of Medical Research – India Diabetes (ICMR INDIAB) study published in August 2023, the prevalence of diabetes will be 10.1 crores in 2022 as the number of individuals diagnosed with diabetes continues to increase in India. Further, according to the International Diabetes Federation Report published in 2023, the number of people diagnosed with diabetes in India is rise to 92.97 million by 2030 and 124.2 million by 2045. As more individuals are diagnosed with diabetes, the need for advanced, user-friendly insulin delivery systems becomes more critical. Smart insulin pens offer numerous benefits, such as precise dosing, data tracking, and enhanced convenience, which make them an attractive option for patients looking to manage their condition more effectively. This growing demand is expected to propel the market’s growth over the forecast period, as technological advancements continue to improve the functionality and accessibility of these devices.
Furthermore, the increasing patient preference for smart insulin pens is significantly driving the market's growth. Patients are increasingly seeking tools that enhance their diabetes management through dose tracking, data sharing with healthcare providers, and reminders for injections. For instance, a study published in the the article Diabetic Therapy in February 2023 stated that diabetic patients highlighted three critical attributes of injectable medications. The survey found that 59.5% of patients prioritized confidence in administering the correct dose, 53.2% emphasized the ease of selecting that dose, and 47.4% highlighted the overall ease of using the injection device as crucial for self-management. Hence, patient preferences for improved management, convenience, and technological integration drive a shift toward smart insulin pens. This trend will significantly boost the smart insulin pens market, providing enhanced diabetes care and better patient outcomes.
Manufacturers are actively focused on acquisition and partnership in the market for global expansion. For instance, in June 2023, Novo Nordisk A/S acquired Biocorp, a French medical device company, to strategically harness its technology and expertise in developing an advanced connected insulin pen. Similarly, in August 2023, Kakao Healthcare, the digital healthcare division of South Korea's Kakao Corporation, partnered with Novo Nordisk to enhance its diabetes management platform by integrating mobile and AI technologies.
Due to the aforementioned factors, such as the rising prevalence of diabetes, the growing patient preference for smart insulin pens, technological advancements, and manufacturers focusing on market activities such as acquisition and partnership, the market is expected to continue to grow in the coming years.
However, the high cost of smart insulin pens will significantly hinder their adoption in the forecast period.
Smart Insulin Pens Market Trends
Diabetes Type I Segment is Expected to Hold a Significant Share in the Market Over the Forecast Period.
Diabetes Type I affects a substantial number of individuals, particularly children and young adults, creating a strong demand for practical management tools. Patients with Type 1 diabetes require precise insulin dosing to manage their blood sugar levels, making smart insulin pens, which offer features like dose tracking and reminders, highly valuable. Smart insulin pens often integrate with digital health platforms, allowing for better data management and monitoring, which is crucial for Type 1 diabetes management.
The rising incidence of Type 1 diabetes is significantly influencing the growth of the smart insulin pens market. As more individuals are diagnosed with this condition, the demand for innovative diabetes management tools increases. Smart insulin pens offer features like dosage tracking, insulin delivery reminders, and integration with mobile apps, making them appealing to patients and healthcare providers. For instance, according to the article published by Journal of Diabetics in April 2024, more than 85% of diabetes cases in individuals under 20 are attributed to type 1 diabetes mellitus (T1DM). Thus, the increasing incidence of Type 1 diabetes is fueling the expansion of the smart insulin pens market.
Additionally, the increasing use of smart insulin pens among Type 1 diabetes patients propels market growth by improving diabetes management with features such as dosage tracking, data sharing, and real-time monitoring. These pens enhance treatment adherence and give patients better insights into their insulin usage. For instance, the article published by the Journal Diabetics Technology and Therapeutics in January 2024 stated that the InPen system, integrating the InPen smart insulin pen with a continuous glucose monitor (CGM), is predominantly utilized by individuals with type 1 diabetes (T1D). With the increasing adoption of smart insulin pens, the demand for these advanced devices is anticipated to rise, driving notable market expansion.
In conclusion, ongoing cases of diabetes type I and patients' growing adoption of smart insulin pens have facilitated significant growth in the diabetes type I segment of the market over the studied period.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Hold a Significant Market Share Over the Forecast Period
North America's market growth is driven by several factors, such as the rising cases of diabetes, advancements in innovative insulin device technology, and manufacturers' increasing focus on activities, including launches.
The rising cases of diabetes, particularly Type 1 and Type 2, are driving the growth of the smart insulin pens market as more patients seek practical management tools. Increased awareness of diabetes management and the need for precise insulin delivery create a greater demand for smart pens, which offer features like dosage tracking and data integration. For instance, according to a report by Diabetes Canada published in July 2023, approximately 4.1 million individuals in Canada were diagnosed with diabetes, including both type 1 and type 2. By 2033, this number is projected to rise to around 5.1 million, representing a 26% increase in 2023
Moreover, according to the New York State Department of Health, in May 2024, approximately 34.5% of adults in the United States have prediabetes. Based on this percentage, it is estimated that up to 5.3 million adult residents of New York City may have prediabetes. Therefore, with a rise in diabetes diagnoses, the demand for sophisticated management tools, particularly those that optimize insulin delivery, will further drive the lucrative growth of market expansion in the North American region.
Furthermore, manufacturers are propelling the growth of the smart insulin pens market through technological advancements. Companies focusing on the launch of smart insulin pens boost the market's growth. In September 2023, Abbott acquired Bigfoot Biomedical, a company specializing in innovative insulin management systems for people with diabetes. This strategic move allows Abbott to broaden its diabetes management portfolio and work on connected solutions for enhanced, personalized patient care.
Therefore, owing to the aforementioned factors, such as the growing number of diabetics, technological advancements for smart insulin pens, and manufacturers focusing on launches, the market is expected to witness significant growth in the region.
Get Analysis on Important Geographic Markets
Download PDF
Smart Insulin Pens Industry Overview
The smart insulin pens market is moderately consolidated due to several companies operating globally and regionally. Major players in the market are focused on product launches and advancements to expand their presence in the global market. The competitive landscape includes analyzing a few international and local companies that hold market shares and are well known, including Eli Lilly and Company, Medtronic plc, Novo Nordisk A/S, Abbott, Sanofi, and others.
Smart Insulin Pens Market Leaders
-
Eli Lilly and Company
-
Medtronic plc
-
Abbott
-
Sanofi
-
Novo Nordisk A/S
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Smart Insulin Pens Market News
- January 2024: BIOCORP obtained 510(K) clearance from the U.S. Food and Drug Administration (FDA) to commercialize SoloSmart, an innovative medical device integrated with Sanofi's SoloStar insulin pens. The SoloSmart sensor is integrated with SoloStar insulin pens to enable digital connectivity. The sensor captured critical treatment metrics, including insulin dosage, injection date, and time. The data is synchronized to a compatible mobile application for user monitoring.
- January 2024: Eli Lilly and Rexam invested in their French manufacturing facilities to produce a new insulin injection pen—this collaboration, which has been developing between Rexam Pharma and Eli Lilly and Co. The insulin injection pen will comprise over a dozen plastic components and a metal spring featuring two sections: one for dose selection and the other serving as a protective cap. The La Verpillière site will handle the production of the pen's sections.
Smart Insulin Pens Industry Segmentation
As per the scope of the report, smart insulin pens are innovative devices designed to administer insulin to diabetes patients. These pens typically incorporate digital technologies, such as Bluetooth connectivity and mobile app integration, enabling users to monitor their glucose levels and track their insulin doses in real-time. Many models include injection reminders and the capability to share data with healthcare providers, thereby enhancing diabetes management. By offering detailed insights and promoting adherence to treatment plans, smart insulin pens aim to improve health outcomes and streamline the diabetes care process. The smart insulin pens market is segmented by indication, connectivity, distribution channel, and geography. By indication, the market is segmented into diabetes type I and diabetes type II. By connectivity, the market is segmented into Bluetooth-connected and near-field communication (NFC) connectivity. By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and E-commerce. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle-East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.
| By Indication | Diabetes Type I | ||
| Diabetes Type II | |||
| By Connectivity | Bluetooth Connected | ||
| Near Field Communication (NFC) Connectivity | |||
| By Distribution Channel | Hospital pharmacies | ||
| Retail pharmacies | |||
| E-commerce | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
Need A Different Region or Segment?
Customize Now
Smart Insulin Pens Market Research FAQs
How big is the Smart Insulin Pens Market?
The Smart Insulin Pens Market size is expected to reach USD 163.64 million in 2025 and grow at a CAGR of 12.45% to reach USD 294.21 million by 2030.
What is the current Smart Insulin Pens Market size?
In 2025, the Smart Insulin Pens Market size is expected to reach USD 163.64 million.
Who are the key players in Smart Insulin Pens Market?
Eli Lilly and Company, Medtronic plc, Abbott, Sanofi and Novo Nordisk A/S are the major companies operating in the Smart Insulin Pens Market.
Which is the fastest growing region in Smart Insulin Pens Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Smart Insulin Pens Market?
In 2025, the North America accounts for the largest market share in Smart Insulin Pens Market.
What years does this Smart Insulin Pens Market cover, and what was the market size in 2024?
In 2024, the Smart Insulin Pens Market size was estimated at USD 143.27 million. The report covers the Smart Insulin Pens Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Smart Insulin Pens Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Smart Insulin Pens Industry Report
Statistics for the 2025 Smart Insulin Pens market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Smart Insulin Pens analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
